-
1.
公开(公告)号:WO2009104819A1
公开(公告)日:2009-08-27
申请号:PCT/JP2009/053623
申请日:2009-02-20
Applicant: OTSUKA PHARMACEUTICAL CO., LTD. , OSHIMA, Kunio , OSHIYAMA, Takashi , TAIRA, Shinichi , MENJO, Yasuhiro , YAMABE, Hokuto , MATSUMURA, Shuuji , UEDA, Masataka , KOGA, Yasuo , TAI, Kuninori , NAKAYAMA, Sunao , ONOGAWA, Toshiyuki , TSUJIMAE, Kenji
Inventor: OSHIMA, Kunio , OSHIYAMA, Takashi , TAIRA, Shinichi , MENJO, Yasuhiro , YAMABE, Hokuto , MATSUMURA, Shuuji , UEDA, Masataka , KOGA, Yasuo , TAI, Kuninori , NAKAYAMA, Sunao , ONOGAWA, Toshiyuki , TSUJIMAE, Kenji
IPC: C07D243/12 , C07D401/12 , C07D401/14 , C07D491/04 , C07D405/14 , C07D417/14 , C07D409/14 , C07D495/04 , C07D471/04 , C07D513/04 , C07D413/14 , A61K31/551 , A61P9/06
CPC classification number: C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D491/04 , C07D495/04 , C07D513/04
Abstract: The present invention provides a novel benzodiazepine compound that blocks the I Kur current or the Kv1.5 channel or the IKACH current (the GIRK1/4 channel) potently and more selectively than other K + channels. The benzodiazepine compound of the invention is represented by General Formula (1) wherein R 1 , R 2 , R 3 , and R 4 are each independently hydrogen or lower alkyl; R 2 and R 3 may be linked to form lower alkylene; A 1 is lower alkylene optionally substituted with one or more hydroxy; and R 5 is group represented by wherein R 6 and R 7 are each independently hydrogen or organic group; X A and X B are each independently bond, lower alkylene, etc.
Abstract translation: 本发明提供了一种新颖的苯并二氮杂类化合物,其比其他K +通道有效地和更有选择地阻断IKur电流或Kv1.5通道或IKACH电流(GIRK1 / 4通道)。 本发明的苯并二氮杂化合物由通式(1)表示,其中R 1,R 2,R 3和R 4各自独立地为氢或低级烷基; R2和R3可以连接形成低级亚烷基; A1是任选被一个或多个羟基取代的低级亚烷基; 并且R 5为其中R 6和R 7各自独立地为氢或有机基团的基团; XA和XB各自独立地键合,低级亚烷基等。
-
2.
公开(公告)号:WO1997012869A1
公开(公告)日:1997-04-10
申请号:PCT/JP1996002892
申请日:1996-10-04
Applicant: OTSUKA PHARMACEUTICAL COMPANY, LIMITED , KOGA, Yasuo , KIHARA, Yoshito , OKADA, Minoru , NISHI, Takao , INOUE, Yoshihiro , KIMURA, Yukio , HIDAKA, Hiroyoshi , FUKUDA, Norio
Inventor: OTSUKA PHARMACEUTICAL COMPANY, LIMITED
IPC: C07D215/22
CPC classification number: C07D215/227
Abstract: A carbostyril derivative of formula (1), wherein A is lower alkylene, R is H, halogen or lower alkoxy, R and R are each lower alkyl being optionally substituted by OH, lower alkoxy, phenyl-lower alkoxy or lower alkanoyloxy; cycloalkyl being optionally substituted by OH, hydroxy-lower alkoxy or lower alkanoyloxy; or amino being optionally substituted by lower alkyl or cycloalkyl, R is H, lower alkyl, lower alkenyl or hydroxy-lower alkyl, and the bond between 3- and 4-positions of the carbostyril nucleus is single or double, provided that when R and R are H, R and R should not be either unsubstituted lower alkyl or unsubstituted cycloalkyl, or a salt thereof, which shows antithrombotic activities, intima thickening inhibitory activity, the platelet mass dissociating activity and increasing activity of the blood flow in the brain and the peripheral vessel, and hence, is useful as medicines in the prophylaxis or treatment of various ischemic diseases.
Abstract translation: 式(1)的喹诺酮衍生物,其中A为低级亚烷基,R为H,卤素或低级烷氧基,R 1和R 2各自为低级烷基,任选被OH,低级烷氧基,苯基 - 低级烷氧基 或低级烷酰氧基; 任选被OH,羟基 - 低级烷氧基或低级烷酰氧基取代的环烷基; 或任选被低级烷基或环烷基取代的氨基,R 3是H,低级烷基,低级烯基或羟基 - 低级烷基,并且喹诺酮核的3-和4-位之间的键是单或双,条件是 当R和R 3为H时,R 1和R 2不应为未经取代的低级烷基或未取代的环烷基或其盐,其显示抗血栓形成活性,内膜增厚抑制活性,血小板质量离解活性 并且增加脑和外周血管中的血流的活性,因此可用作预防或治疗各种缺血性疾病的药物。
-
3.
公开(公告)号:WO2011021726A2
公开(公告)日:2011-02-24
申请号:PCT/JP2010064545
申请日:2010-08-20
Applicant: OTSUKA PHARMA CO LTD , OSHIMA KUNIO , MATSUMURA SHUUJI , YAMABE HOKUTO , ISONO NAOHIRO , TAKEMURA NORIAKI , TAIRA SHINICHI , OSHIYAMA TAKASHI , MENJO YASUHIRO , NAGASE TSUYOSHI , UEDA MASATAKA , KOGA YASUO , NAKAYAMA SUNAO , TSUJIMAE KENJI , ONOGAWA TOSHIYUKI , TAI KUNINORI , ITOTANI MOTOHIRO
Inventor: OSHIMA KUNIO , MATSUMURA SHUUJI , YAMABE HOKUTO , ISONO NAOHIRO , TAKEMURA NORIAKI , TAIRA SHINICHI , OSHIYAMA TAKASHI , MENJO YASUHIRO , NAGASE TSUYOSHI , UEDA MASATAKA , KOGA YASUO , NAKAYAMA SUNAO , TSUJIMAE KENJI , ONOGAWA TOSHIYUKI , TAI KUNINORI , ITOTANI MOTOHIRO
IPC: C07D243/12 , A61K31/4704 , A61K31/496 , A61K31/498 , A61K31/4985 , A61K31/506 , A61K31/517 , A61K31/551 , A61K31/553 , A61K31/554 , C07D215/227 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/14 , C07D407/14 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04 , C07D491/048 , C07D495/04 , C07D519/00
CPC classification number: C07D491/048 , C07D213/38 , C07D215/227 , C07D243/12 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D495/04
Abstract: The present invention provides a novel diazepine compound that blocks the IKur current or the Kv1.5 channel potently and more selectively than other K+ channels. The present invention relates to a diazepine compound represented by General Formula (1) or a salt thereof, wherein R1, R2, R3, and R4 are each independently hydrogen, lower alkyl, cyclo lower alkyl or lower alkoxy lower alkyl; R2 and R3 may be linked to form lower alkylene; A1 is lower alkylene optionally substituted with one or more substituents selected from the group consisting of hydroxyl and oxo; Y1 and Y2 are each independently -N= or -CH=; and R5 is group represented by (2) wherein R6 and R7 are each independently hydrogen or organic group; R6 and R7 may be linked to form a ring together with the neighboring group -XA-N-XB-; XA and XB are each independently a bond, lower alkylene, etc.
Abstract translation: 本发明提供了一种新颖的二氮杂类化合物,其比其他K +通道有效地和选择性地阻断IK电流或Kv1.5通道。 本发明涉及由通式(1)表示的二氮杂化合物或其盐,其中R 1,R 2,R 3和R 4各自独立地为氢,低级烷基,环低级烷基或低级烷氧基低级烷基; R2和R3可以连接形成低级亚烷基; A1是任选被一个或多个选自羟基和氧代的取代基取代的低级亚烷基; Y1和Y2各自独立地为-N =或-CH =; R5为由(2)表示的基团,其中R6和R7各自独立地为氢或有机基团; R6和R7可以与相邻基团-XA-N-XB-一起形成环; XA和XB各自独立地为键,低级亚烷基等
-
4.
公开(公告)号:WO2011021726A3
公开(公告)日:2011-02-24
申请号:PCT/JP2010/064545
申请日:2010-08-20
Applicant: OTSUKA PHARMACEUTICAL CO., LTD. , OSHIMA, Kunio , MATSUMURA, Shuuji , YAMABE, Hokuto , ISONO, Naohiro , TAKEMURA, Noriaki , TAIRA, Shinichi , OSHIYAMA, Takashi , MENJO, Yasuhiro , NAGASE, Tsuyoshi , UEDA, Masataka , KOGA, Yasuo , NAKAYAMA, Sunao , TSUJIMAE, Kenji , ONOGAWA, Toshiyuki , TAI, Kuninori , ITOTANI, Motohiro
Inventor: OSHIMA, Kunio , MATSUMURA, Shuuji , YAMABE, Hokuto , ISONO, Naohiro , TAKEMURA, Noriaki , TAIRA, Shinichi , OSHIYAMA, Takashi , MENJO, Yasuhiro , NAGASE, Tsuyoshi , UEDA, Masataka , KOGA, Yasuo , NAKAYAMA, Sunao , TSUJIMAE, Kenji , ONOGAWA, Toshiyuki , TAI, Kuninori , ITOTANI, Motohiro
IPC: C07D243/12 , C07D401/12 , C07D401/14 , C07D403/12 , C07D407/14 , C07D409/12 , C07D409/14 , C07D413/14 , C07D417/14 , C07D491/048 , C07D495/04 , C07D401/06 , C07D403/06 , C07D403/14 , C07D405/14 , C07D413/06 , C07D413/12 , C07D519/00 , C07D471/04 , C07D215/227 , A61K31/551 , A61K31/506 , A61K31/4704 , A61K31/496 , A61K31/498 , A61K31/517 , A61K31/554 , A61K31/553 , A61K31/4985
Abstract: The present invention provides a novel diazepine compound that blocks the I Kur current or the Kv1.5 channel potently and more selectively than other K + channels. The present invention relates to a diazepine compound represented by General Formula (1) or a salt thereof, wherein R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, lower alkyl, cyclo lower alkyl or lower alkoxy lower alkyl; R 2 and R 3 may be linked to form lower alkylene; A 1 is lower alkylene optionally substituted with one or more substituents selected from the group consisting of hydroxyl and oxo; Y 1 and Y 2 are each independently -N= or -CH=; and R 5 is group represented by (2) wherein R 6 and R 7 are each independently hydrogen or organic group; R 6 and R 7 may be linked to form a ring together with the neighboring group -X A -N-X B -; X A and X B are each independently a bond, lower alkylene, etc.
-
公开(公告)号:WO1989010919A1
公开(公告)日:1989-11-16
申请号:PCT/JP1989000464
申请日:1989-05-02
Applicant: OTSUKA PHARMACEUTICAL CO., LTD. , NISHI, Takao , KOMATSU, Makoto , KOGA, Yasuo , SHU, Yoshio , TAMURA, Katsumi
Inventor: OTSUKA PHARMACEUTICAL CO., LTD.
IPC: C07D215/22
CPC classification number: C07D215/227 , C07D231/12 , C07D233/56 , C07D249/08 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D411/12 , C07D417/12
Abstract: This invention relates to carbostyril derivatives represented by general formula (1), a process for their preparation, and an agent for inhibiting agglutination of platelets containing them as an active ingredient, wherein A represents a lower alkylene group, R1 represents a substituted or unsubstituted cycloalkyl-lower alkyl group, a cycloalkyl group, a tetrahydropyranyl-lower alkyl group, a lower alkylenedioxy-substituted lower alkyl group, a substituted phenyl-lower alkyl group or a lower alkyl-substituted piperidinyl-lower alkyl group, R2 represents a substituted or unsubstituted 5- or 6-membered, saturated or unsaturated heterocyclic-lower alkyl group, a tetrahydropyranylthio-lower alkyl group, a pyridylthio-lower alkyl group, a lower alkylene-dioxy-substituted lower alkyl group or a substituted or unsubstituted lower alkyl group, and the carbon-to-carbon bond between the 3-position and the 4-position of the carbostyril skeleton represents either a single or a double bond.
-
-
-
-